TickerFactsScreenerDevelopers

HALOZYME THERAPEUTICS, INC. (HALO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: -$40.15M2010: -$45.39M2011: -$34.30M2012: -$64.28M2013: -$49.34M2014: -$47.52M2015: -$37.08M2016: -$50.38M2017: $134.05M2018: -$49.50M2019: -$85.42M2020: $55.45M2021: $299.44M2022: $240.11M2023: $388.57M2024: $479.06M2025: $651.56M$651.56M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$651.56M+36.0%
2024$479.06M+23.3%
2023$388.57M+61.8%
2022$240.11M-19.8%
2021$299.44M+440.0%
2020$55.45M+164.9%
2019-$85.42M-72.6%
2018-$49.50M-136.9%
2017$134.05M+366.1%
2016-$50.38M-35.9%
2015-$37.08M+22.0%
2014-$47.52M+3.7%
2013-$49.34M+23.2%
2012-$64.28M-87.4%
2011-$34.30M+24.4%
2010-$45.39M-13.0%
2009-$40.15M—